Trulock E P
Lung Transplant Program, Washington University-Barnes Hospital, St. Louis, USA.
Chest. 1996 Dec;110(6 Suppl):284S-294S. doi: 10.1378/chest.110.6_supplement.284s.
Lung transplantation is an option for appropriately selected patients with end-stage emphysema caused by alpha 1-antitrypsin deficiency. The functional results have been excellent after single or bilateral lung transplantation, and the medium-term survival results have been good. However, the role of alpha 1-antitrypsin replacement therapy after lung transplantation remains uncertain, and further investigation is needed.
对于因α1抗胰蛋白酶缺乏引起的终末期肺气肿患者,肺移植是一种可供适当选择的治疗方案。单肺或双肺移植后的功能结果极佳,中期生存结果良好。然而,肺移植后α1抗胰蛋白酶替代疗法的作用仍不明确,需要进一步研究。